Study in healthy males to assess bioavailability of 4 different fostamatinib tablets

Study identifier:D4300C00016

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An Open-label, Randomized, Four-way Crossover Study in Healthy Male Subjects to Assess the Relative Bioavailability of 4 Different Fostamatinib Tablets

Medical condition

Bioavailability, pharmacokinetics

Phase

Phase 1

Healthy volunteers

Yes

Study drug

Fostamatinib

Sex

Male

Actual Enrollment

24

Study type

Interventional

Age

18 Years - 55 Years

Date

Study Start Date: 01 Sept 2010
Primary Completion Date: 01 Nov 2010
Study Completion Date: 01 Nov 2010

Study design

Allocation: Randomized
Endpoint Classification: Pharmacokinetics Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Basic Science

Verification:

Verified 01 Jan 2014 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria